Sign inJoin waitlistJoin the waitlist

IS

Ibrahim Sahin

Physician · University of Michigan Health-Ann Arbor

Credentials: · · · · · · ·

History

University of Michigan Health-Ann Arbor
2026–Present

Hematology and Medical Oncology
Emory University School of Medicine
2017–2020
Internal Medicine
Icahn School of Medicine at Mount Sinai
2013–2016
Doctor of Medicine
2005–2009

Research

Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
Review · British Journal of Cancer · 2019 · First of 7 authors · Corresponding · 320 citations
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
Clinical Cancer Research · 2018 · 307 citations
Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer
PLoS ONE · 2012 · 100 citations

AS
Anwaar Saeed
20 papers
Hao Xie
11 papers · 2 as a fellow
SF
Seth Felder
11 papers
II
Iman Imanirad
9 papers
Aatur Singhi
8 papers
MS
Masood Pasha Syed
8 papers · 6 as a fellow
EO
Eileen O'Reilly
7 papers
JF
Jessica Frakes
7 papers
RK
Richard Kim
7 papers
TS
Turcin Saridogan
7 papers · 7 as a resident
ET
Elaine Tan
6 papers · 6 as a fellow
TM
Tara Magge
6 papers · 6 as a fellow

Clinical trials

Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers
Principal investigator · Withdrawn · Phase 2
Ibrahim Halil Sahin
2025–2028